Considering the regulation of metabolic reprogramming in prostate cancer by SREBF1 and its relationship with ferroptosis, we investigated the effect of the SREBF1 inhibitor Betulin on promoting ferroptosis in prostate cancer. This evidence concerns the gene SREBF1 and Familial prostate cancer.